PURPOSE This review arms practitioners with the evidence-based information they need to fully manage myopia. RECENT FINDINGS The recent peer-reviewed literature is critically evaluated to provide a comprehensive analysis of the safety and efficacy of behavioural, optical and pharmaceutical myopia management. Importantly, the paper addresses not only who to treat, but how to treat them, and when to stop or modify treatments. Finally, the paper discusses expectations for treatment and why slowing myopia by even 1 dioptre improves long term health outcomes. SUMMARY The management of an individual child should be underpinned by the evidence-based literature and clinicians must stay alert to ongoing myopia research that will undoubtedly result in an evolution of the standard of care for the myopic and pre-myopic child.

中文翻译：

---

近视控制2020：我们要去哪里，要去哪里？

目的这篇综述为从业人员提供了充分管理近视所需的循证信息。最近的发现最近对经过同行评审的文献进行了严格的评估，以提供对行为，光学和药物近视治疗的安全性和有效性的全面分析。重要的是，本文不仅论述了要治疗的人，还探讨了如何治疗他们以及何时停止或改变治疗方法。最后，本文讨论了对治疗的期望以及为什么将近视减慢甚至1屈光度可以改善长期健康结果。小结儿童的管理应以循证文献为基础，临床医生必须对正在进行的近视研究保持警惕，这无疑会导致近视和近视前儿童的护理标准不断发展。